Skip to main content

Setia Vishwas's Form 4 filing

MapLight Therapeutics, Inc. (MPLT) · filed May 6, 2026

Accession no.
0002021256-26-000008
Filed
May 6, 2026
Trade date
May 4-6, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.02M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Setia VishwasCIK 0002021256Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 4, 2026Voting Common StockSSaleDisposed−4,803$27.36−$131,410.08387,824Direct
May 4, 2026Voting Common StockSSaleDisposed−8,989$28.28−$254,208.92378,835Direct
May 4, 2026Voting Common StockSSaleDisposed−325$29.56−$9,607378,510Direct
May 4, 2026Voting Common StockSSaleDisposed−787$30.12−$23,704.44377,723Direct
May 5, 2026Voting Common StockSSaleDisposed−9,935$28.12−$279,372.2367,788Direct
May 5, 2026Voting Common StockSSaleDisposed−968$29.00−$28,072366,820Direct
May 6, 2026Voting Common StockSSaleDisposed−8,496$28.04−$238,227.84358,324Direct
May 6, 2026Voting Common StockSSaleDisposed−2,068$29.07−$60,116.76356,256Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)